Announcements Trials

Browse Landscape

Phase

Phase 2 39 Phase 3 22 Phase NA 8 Phase 1 7 Phase 1/2 6 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Sarcoma 1 Mediastinal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Intracranial Germ Cell Tumors 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

anlotinib 1 Tranexamic Acid 1 Indocyanine Green 1 Ifosfamide 1 Hyperbaric Oxygenation 1 Enoxaparin 1 Doxorubicin 1 Brachytherapy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Sarcoma × Ifosfamide × Clear all

NCT03514381 2026-04-14

IPIAP-STM

Institut Claudius Regaud

Phase 4 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡